AO estimates breast cancer-specific mortality and recurrence after surgery for various chemotherapy and hormonal treatment options based on the patient’s age, comorbidities, estrogen receptor status, tumor size, tumor grade and number of positive lymph nodes (Adjuvant! Online Inc 2012). Here, ESR1 is linked to breast carcinoma.